Best GLP-1 for Women: Ranked
The drugs work the same way in everyone, but the considerations around them do not. PCOS, the menopause transition, returning fertility, unreliable contraception, hair shedding, and bone density are all things most GLP-1 guides skip entirely.
Last updated: August 3, 2026
Best Overall for Women: Coreage Rx
Two things shape this recommendation. First, women are disproportionately likely to be denied coverage - PCOS has no approved GLP-1 indication, and menopausal weight gain is not a covered diagnosis. Second, treatment tends to run for years rather than months, so what you can sustain matters more than the last percentage point.
Coreage Rx addresses both. Physician-supervised compounded semaglutide starts at $249/month all-inclusive - consultation, medication, shipping, and ongoing dose management in one flat price, with no insurance required and no prior authorisation to fight.
Why Coreage Rx Ranks First
- No insurance battle - the main obstacle for PCOS and menopause patients disappears
- Semaglutide, which has the most PCOS-specific research behind it
- Ongoing physician contact - essential for managing hair shedding, titration pace, and pregnancy planning
- Sustainable at ~$3,000/year rather than $5,400+, which matters over a multi-year course
- Month-to-month, important if you plan to stop before conceiving
- US board-certified physicians handling consultation and monitoring
Two Things Every Woman Should Know Before Starting
1. GLP-1s are contraindicated in pregnancy. If you may conceive, you need a prescriber-directed washout period before trying - these drugs have long half-lives.
2. They can reduce oral contraceptive reliability. Slowed gastric emptying affects absorption, and vomiting during titration compounds it. Combined with returning fertility from weight loss, this is a genuine cause of unplanned pregnancy. Discuss a backup or non-oral method with your prescriber.
The Rankings
| Rank | Option | Weight Loss | Best For |
|---|---|---|---|
| 🏆 #1 | Coreage Rx (compounded semaglutide) ⭐ | ~15% | Access without insurance; sustainable multi-year cost |
| #2 | Zepbound (tirzepatide) | ~20-22% | Maximum effect; strongest insulin sensitivity for PCOS |
| #3 | Wegovy (semaglutide 2.4 mg) | ~15% | Broadest approved indications; molecule used in PCOS research |
| #4 | Foundayo (orforglipron) | 14.1-14.4% in menopause subgroups | Best menopause-specific data; oral, no timing rules |
| #5 | Wegovy Pill (oral semaglutide) | 13.6-16.6% | Strong results if the daily empty-stomach routine fits |
Tirzepatide is the most effective and has the strongest insulin sensitivity effect, which maps well onto PCOS. Foundayo has the best published menopause-specific data. Our top pick is an affordable semaglutide programme because access and sustainability are, for most women, the binding constraint rather than the choice between molecules.
Do GLP-1s Work Differently in Women?
The mechanism is identical, and the trial evidence does not support the common assumption that hormonal status blunts these drugs.
The most useful data comes from menopause subgroup analyses, which cut against expectations:
- In ATTAIN-1, perimenopausal women lost up to 30.4 lbs (14.4%) and postmenopausal women up to 28.2 lbs (14.1%) on Foundayo - both above the overall trial average of 11.2-12.4%.
- In oral semaglutide analyses presented at ObesityWeek, 58.1% of premenopausal and 56.5% of perimenopausal women achieved more than 15% weight loss - a gap of just 1.6 percentage points.
If you have been told these drugs will not work for you because of your hormones, that is not what the data shows. Both menopause subgroups met or exceeded overall averages. It is worth bringing to a prescriber who is hesitant.
If You Have PCOS
PCOS is fundamentally metabolic, which is why GLP-1s address it more directly than most treatments. Insulin resistance drives high circulating insulin, which stimulates ovarian androgen production, which disrupts ovulation.
The evidence indicates GLP-1 receptor agonists help overweight or obese women with PCOS achieve more regular menstrual cycles and increased spontaneous ovulation, with meta-analysis evidence showing improved natural pregnancy rates. The RESTORE trial is examining semaglutide specifically in PCOS, with early findings suggesting benefits beyond weight loss alone.
Critically, research indicates losing 5% or more of body weight can improve metabolic and reproductive symptoms - a low threshold relative to what GLP-1s deliver, which is why many women see cycle improvements well before reaching their overall goal.
Full detail in our best GLP-1 for PCOS guide.
If You Are in Perimenopause or Menopause
Midlife weight gain has several compounding drivers: declining oestrogen shifts fat storage toward the abdomen, age-related muscle loss accelerates and lowers resting metabolic rate, insulin sensitivity declines, and hot flushes fragment sleep - which raises ghrelin and lowers leptin.
A GLP-1 addresses appetite and insulin sensitivity powerfully. It does not address muscle loss, and can worsen it if you do nothing - which is why the training and protein side is not optional at this life stage.
One practical note on HRT: GLP-1s slow gastric emptying, which can theoretically affect absorption of oral medications including oral hormone therapy. Transdermal formulations bypass this. Make sure whoever manages your menopause care knows about your GLP-1.
Full detail in our best GLP-1 for menopause guide.
Fertility and Contraception
This deserves more attention than it usually gets, because two effects compound in a way that catches people out.
Fertility can return unexpectedly
Many women with PCOS are subfertile specifically because they ovulate irregularly. Weight loss and improved insulin sensitivity can restore ovulation - sometimes quickly, and often to women who had assumed conceiving would be difficult.
Oral contraception may become less reliable
Slowed gastric emptying can affect absorption of oral contraceptives, and vomiting or diarrhoea during titration compounds the risk. Returning fertility plus reduced contraceptive reliability is exactly how unplanned pregnancies happen on these medications.
GLP-1 medications are contraindicated in pregnancy. If you are using one to improve fertility, the plan must include stopping before you conceive - not after you find out.
Because these drugs have long half-lives - semaglutide's is roughly a week - your prescriber will advise a washout period. Ask specifically how long before you start trying. If you are not trying to conceive, discuss a backup or non-oral contraceptive method, particularly during dose escalation.
Hair, Bone, and Muscle
Hair shedding
Roughly 4-5% of Zepbound trial participants reported hair loss. It is almost always telogen effluvium - temporary shedding triggered by rapid weight loss and reduced nutrient intake, not a direct drug effect on follicles - and it regrows.
If you are also perimenopausal, you may be experiencing two processes at once, since declining oestrogen independently causes thinning. Full detail in our GLP-1 hair loss guide.
Bone density
Postmenopausal women already face accelerated bone loss, and weight loss by any method is associated with some reduction in bone mineral density. This is a reason for deliberate management rather than avoidance: resistance training protects bone as well as muscle, adequate calcium and vitamin D matter more during active loss, and avoiding very rapid loss helps. Discuss a baseline DEXA scan if you have risk factors.
Muscle preservation
Women typically start with less lean mass than men and lose it faster after menopause, which makes this more consequential rather than less. Target roughly 0.7-1.0 g of protein per pound of goal body weight daily and resistance train two to three times weekly. See our muscle loss prevention guide.
A pattern worth noticing: protein intake fixes or mitigates all three of these. Hair is keratin, bone maintenance depends on adequate nutrition, and muscle preservation is almost entirely a protein-and-training problem. If you do one thing beyond taking the medication, track your protein for a week - most women on a GLP-1 are eating far less than they think.
The Coverage Problem
Women face a particular version of the insurance problem, because the two most common reasons they seek treatment are not covered diagnoses.
- PCOS has no FDA-approved GLP-1 indication. All prescribing is off-label, so insurers have nothing to authorise against.
- Menopausal weight gain is not a diagnosis insurers recognise for this purpose.
- Many plans exclude weight loss medications entirely as a category.
Routes That Sometimes Work
- Document insulin resistance or prediabetes - a diabetes-indicated GLP-1 may be coverable on that basis
- Apply under the obesity indication if your BMI qualifies
- Get assessed for sleep apnea. It is dramatically underdiagnosed in women, and Zepbound holds the only FDA approval for moderate-to-severe OSA - a much stronger claim. See our sleep apnea guide.
- Document comorbidities - hypertension, dyslipidaemia, fatty liver all strengthen a prior authorisation
- Appeal denials, which are frequently overturned
For the full picture on which indications unlock coverage, see our guide to every FDA-approved GLP-1 indication.
Our #1 Pick: Coreage Rx from $249/month
Skip the insurance fight entirely. Physician-supervised compounded semaglutide with consultation, medication, shipping, and ongoing dose management in one flat monthly price - prescribed by US board-certified physicians, with no prior authorisation and month-to-month flexibility.
Frequently Asked Questions
What is the best GLP-1 for women?
Tirzepatide is most effective overall at 20-22% and has the strongest insulin sensitivity effect, which suits PCOS. Foundayo has the best published menopause-specific data. Semaglutide has the most PCOS research behind it and the broadest approved indications. In practice the deciding factor is usually access - women are disproportionately likely to be denied coverage, since neither PCOS nor menopausal weight gain is a covered indication.
Do GLP-1s work as well for women in menopause?
The subgroup data says yes, and possibly better. In ATTAIN-1, perimenopausal women lost up to 14.4% and postmenopausal women up to 14.1% - both above the overall trial average. In oral semaglutide analyses, 58.1% of premenopausal and 56.5% of perimenopausal women achieved more than 15% weight loss, a difference of only 1.6 percentage points.
Do GLP-1s affect birth control?
They can. Slowed gastric emptying may affect absorption of oral contraceptives, and vomiting or diarrhoea during titration compounds the risk. Because weight loss can simultaneously restore ovulation and return fertility, this combination is a genuine cause of unplanned pregnancy. If you are not trying to conceive, discuss a backup or non-oral method with your prescriber, especially during dose escalation.
Can I take a GLP-1 while trying to get pregnant?
No. GLP-1 medications are contraindicated in pregnancy and must be stopped before conceiving rather than after you find out. Because these drugs have long half-lives - semaglutide's is roughly a week - your prescriber will advise a specific washout period. Ask exactly how long before you begin trying. This is essential if fertility is part of why you are taking one.
Will a GLP-1 help my PCOS symptoms?
Evidence indicates GLP-1 receptor agonists help overweight or obese women with PCOS achieve more regular menstrual cycles and increased spontaneous ovulation, with meta-analysis evidence showing improved natural pregnancy rates. Research suggests losing 5% or more of body weight can improve both metabolic and reproductive symptoms, which is a low threshold relative to what these drugs deliver - so cycle improvements often appear before you reach your overall goal.
Will I lose my hair on a GLP-1?
Roughly 4-5% of Zepbound trial participants reported hair loss, so most people do not. When it happens it is almost always telogen effluvium - temporary shedding triggered by rapid weight loss and reduced nutrient intake rather than a direct drug effect - and it regrows over roughly nine to eighteen months. Adequate protein and a sensible rate of loss are the main protective factors.
Can I take a GLP-1 with HRT?
They address different problems and are commonly used together. One practical caution: GLP-1s slow gastric emptying, which can theoretically affect absorption of oral medications including oral hormone therapy - transdermal formulations bypass this concern. Make sure whoever manages your menopause care knows about your GLP-1, since these are frequently different clinicians.
Why is it so hard to get covered for PCOS?
Because no GLP-1 carries an FDA-approved PCOS indication, insurers have no approved use to authorise against, and many plans additionally exclude weight loss medications as a category. Practical workarounds include documenting insulin resistance or prediabetes, applying under an obesity indication if your BMI qualifies, getting assessed for sleep apnea since Zepbound holds that indication, documenting comorbidities, and appealing first denials.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are contraindicated in pregnancy and must be discontinued with a prescriber-directed washout period before conceiving. They may also reduce the reliability of oral contraceptives. No GLP-1 is FDA-approved for PCOS or for menopausal weight gain; such use is off-label and requires a prescriber's clinical judgement. PCOS, menopause care, hormone replacement therapy, fertility planning, and bone health should be directed by qualified clinicians. Clinical trial subgroup analyses cited come from studies not primarily designed to answer women-specific questions and do not predict individual results. Rankings reflect our editorial assessment. HealthyPound may receive compensation from affiliate partners mentioned in this article, including Coreage Rx. See our affiliate disclosure and full medical disclaimer.